Is afatinib effective?

Afatinib is an oral, targeted therapy commonly used to treat certain types of cancer, particularly non-small cell lung cancer (NSCLC). It belongs to a class of drugs called tyrosine kinase inhibitors, which inhibit certain protein kinases in cancer cells, thereby slowing or stopping the growth and spread of tumors. The effectiveness of medications varies from person to person and depends on factors such as the patient's individual condition, condition, and type of cancer. In some patients, afatinib may show positive therapeutic effects, prolonging survival, slowing tumor progression, and bringing about relief of other symptoms.